Rani Therapeutics Holdings Inc - Ordinary Shares Class A

NASDAQ:RANI 4:00:00 PM EDT

5.55

-0.02 (-0.36%)

5:47:53 PM EDT: $5.82 +0.27 (+4.87%)

Market Cap (Intraday)	136.70M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.11 Million
Adjusted EPS	-$0.41

See more estimates

10-Day MA	$5.73
50-Day MA	$6.77
200-Day MA	$9.14

See more pivots

Rani Therapeutics Holdings Inc - Ordinary Shares Class A Stock, NASDAQ:RANI

2051 Ringwood Avenue, San Jose, California 95131

United States of America

Phone: +1.408.457.3700

Number of Employees: 114

http://www.ranitherapeutics.com

Description

Rani Therapeutics Holdings, Inc. operates as a clinical stage bio-therapeutics company providing technologies to enable the development of orally administered biologics. It offers RaniPill capsule, an orally ingestible pill for the administration of a broad range of biologics. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.